Abstract:The incidence of chronic liver disease is constantly increasing, owing to the obesity epidemic. However, the causes and mechanisms of inflammation-mediated liver damage remain poorly understood. Endoplasmic reticulum (ER) stress is an initiator of cell death and inflammatory mechanisms. Although obesity induces ER stress, the interplay between hepatic ER stress, NLRP3 inflammasome activation and hepatocyte death signaling has not yet been explored during the etiology of chronic liver diseases. Steatosis is a common disorder affecting obese patients; moreover, 25% of these patients develop steatohepatitis with an inherent risk for progression to hepatocarcinoma. Increased plasma LPS levels have been detected in the serum of patients with steatohepatitis. We hypothesized that, as a consequence of increased plasma LPS, ER stress could be induced and lead to NLRP3 inflammasome activation and hepatocyte death associated with steatohepatitis progression. In livers from obese mice, administration of LPS or tunicamycin results in IRE1α and PERK activation, leading to the overexpression of CHOP. This, in turn, activates the NLRP3 inflammasome, subsequently initiating hepatocyte pyroptosis (caspase-1, -11, interleukin-1β secretion) and apoptosis (caspase-3, BH3-only proteins). In contrast, the LPS challenge is blocked by the ER stress inhibitor TUDCA, resulting in: CHOP downregulation, reduced caspase-1, caspase-11, caspase-3 activities, lowered interleukin-1β secretion and rescue from cell death. The central role of CHOP in mediating the activation of proinflammatory caspases and cell death was characterized by performing knockdown experiments in primary mouse hepatocytes. Finally, the analysis of human steatohepatitis liver biopsies showed a correlation between the upregulation of inflammasome and ER stress markers, as well as liver injury. We demonstrate here that ER stress leads to hepatic NLRP3 inflammasome pyroptotic death, thus contributing as a novel mechanism of inflammation-mediated liver injury in chronic liver diseases. Inhibition of ER-dependent inflammasome activation and cell death pathways may represent a potential therapeutic approach in chronic liver diseases.

ER Stress Activates the NLRP3 Inflammasome Via an UPR-independent Pathway

Endoplasmic Reticulum Stress is Sufficient for the Induction of IL-1β Production Via Activation of the NF-κB and Inflammasome Pathways

Endoplasmic Reticulum Stress and NLRP3 Inflammasome: Crosstalk in Cardiovascular and Metabolic Disorders

NOD1 and NOD2 signalling links ER stress with inflammation

The unfolded protein response: controlling cell fate decisions under ER stress and beyond

At the Crossway of ER‐stress and Proinflammatory Responses

The kinase receptor-interacting protein 1 is required for inflammasome activation induced by endoplasmic reticulum stress

ER-mitochondria communication is involved in NLRP3 inflammasome activation under stress conditions in the innate immune system

ER Stress Responses: An Emerging Modulator for Innate Immunity

The Roles of Endoplasmic Reticulum in NLRP3 Inflammasome Activation

The Nlrp3 Inflammasome: A Sensor for Metabolic Danger?

The Role of the Effects of Endoplasmic Reticulum Stress on NLRP3 Inflammasome in Diabetes

ER stress induces NLRP3 inflammasome activation and hepatocyte death

Structure and Molecular Mechanism of ER Stress Signaling by the Unfolded Protein Response Signal Activator IRE1

Mapping the Crossroads of Immune Activation and Cellular Stress Response Pathways

The Role of Endoplasmic Reticulum Stress and NLRP3 Inflammasome in Liver Disorders

Endoplasmic reticulum stress regulates the innate immunity critical transcription factor IRF3.

Endoplasmic Reticulum Stress-Induced NLRP1 Inflammasome Activation Contributes to Myocardial Ischemia/Reperfusion Injury.

Emerging insights into the role of NLRP3 inflammasome and endoplasmic reticulum stress in renal diseases

METABOLISM. S-Nitrosylation links obesity-associated inflammation to endoplasmic reticulum dysfunction

ER Stress-induced Inflammasome Activation Contributes to Hepatic Inflammation and Steatosis